Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II.
暂无分享，去创建一个
F. Khuri | W. Miller | J. von Pawel | U. Gatzemeier | G. Blumenschein | A. Negro-Vilar | R. Jotte | Jinkun Zhang | J. Le Treut | Show-Li Sun | Z. Dziewanowska | Jin-kun Zhang